Please see our Annual Report for 2017-18 here.
You can read our Annual Review for the year ending 31st March 2017 here.
Some of our key highlights were:
- Our Family Support team continued to act as a trusted guide, helping 54 families navigate their way through the health system, both in the UK and abroad.
- Our fifth annual Neuroblastoma Parent Education Conference (2016) was a great success – bringing together leading neuroblastoma experts from around the globe and families affected by the disease.
- We committed almost £200,000 to ground-breaking neuroblastoma research.
- We became the first charity ever to successfully challenge the National Institute for Health and Care Excellence (NICE) on its decision not to approve dinutuximab (a drug shown to increase survival for patients with high-risk neuroblastoma) for use by the NHS.